ESC Premium Access

Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the spironolactone for heart failure with preserved ejection fraction (TOPCAT) trial

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Congress Presentation

About the speaker

Doctor Corrado De Marco

University of Montreal, Montreal (Canada)
0 follower

8 more presentations in this session

Impact of left-ventricular hemodynamics on treadmill exercise intolerance in conscious rats: Pilot evaluation in animals with diastolic dysfunction

Speaker: Doctor B. Ferguson (South San Francisco, US)

Thumbnail

Subcutaneous delivery of NPA7, first-in-class novel bispecific designer peptide: enhances cardiorenal function and suppresses renin and aldosterone in vivo and in vitro

Speaker: Associate Professor S. Sugihara (Izumo, JP)

Thumbnail

Volume overload-triggered pathological myocardial remodeling occurs in the absence of calcium/calmodulin-dependent protein kinase type II delta

Speaker: Doctor M. Elkenani (Gottingen, DE)

Thumbnail

Chronic cardiac allograft rejection after heterotopic rat heart transplantation: ed-a but not ed-b domain containing fibronectin as novel serum biomarker of cardiac allograft vasculopathy

Speaker: Professor M. Franz (Rotenburg an der Fulda, DE)

Thumbnail

Purinergic receptor Y6 (P2Y6) deficiency impairs left ventricular function

Speaker: Doctor I. Schaefer (Basel, CH)

Thumbnail

Access the full session

Poster Session 7 - Heart Failure Basic Science

Speakers: Doctor C. De Marco, Doctor B. Ferguson, Associate Professor S. Sugihara, Doctor M. Elkenani, Professor M. Franz...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb